Cholesterol drug joins fight against stubborn lung cancer
Disease control
Not yet recruiting
This early-stage study is testing if adding a cholesterol-lowering drug called pitavastatin to personalized chemotherapy can help control advanced non-small cell lung cancer that has stopped responding to standard treatments. Doctors will test tumor cells from each patient in a l…
Phase: PHASE1 • Sponsor: Chang Chen • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC